Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

ARYX Insider Trading

ARYX | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at ARYX provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2011-03-14 20:59 2011-03-10 DRANT RYAN D 10% owner SELL $0.07 4,469,274 $326,257 0 -100.0%
2011-03-14 20:59 2011-03-10 BASKETT FOREST 10% owner SELL $0.07 4,469,274 $326,257 0 -100.0%
2011-03-14 20:58 2011-03-10 KOLLURI KRISHNA KITTU 10% owner SELL $0.07 4,469,274 $326,257 0 -100.0%
2011-03-14 20:56 2011-03-10 KERINS PATRICK J 10% owner SELL $0.07 4,469,274 $326,257 0 -100.0%
2011-03-14 20:59 2011-03-10 Growth Equity Opportunities Fund, LLC 10% owner SELL $0.07 4,469,274 $326,257 0 -100.0%
2009-05-26 23:56 2009-05-22 ORBIMED ADVISORS LLC 10% owner SELL $4.00 2,000,000 $8,000,000 1,340,139 -59.9%
2008-11-19 00:39 2008-11-14 Adelman Robert J Director, 10% owner BUY $0.00 1,214,646 $0 3,340,139 +57.1%
2008-11-18 23:10 2008-11-14 ORBIMED ADVISORS LLC 10% owner BUY $0.00 1,214,646 $0 3,340,139 +57.1%
2008-11-18 03:18 2008-11-14 SIMON NICHOLAS J III Director, 10% owner BUY $2.20 1,787,710 $3,932,962 5,364,572 +50.0%
2008-11-18 03:23 2008-11-14 MPM BIOVENTURES III QP LP 10% owner BUY $2.20 1,787,710 $3,932,962 5,364,572 +50.0%
2008-11-18 03:15 2008-11-14 EVNIN LUKE 10% owner BUY $2.20 1,787,710 $3,932,962 5,364,572 +50.0%
2007-11-15 23:56 2007-11-13 ORBIMED ADVISORS LLC Director BUY $10.00 300,000 $3,000,000 2,125,493 +16.4%
2007-11-15 02:07 2007-11-13 Adelman Robert J Director, 10% owner BUY $10.00 300,000 $3,000,000 300,000 +100.0%
2007-11-13 21:38 2007-11-13 SIMON NICHOLAS J III Director, 10% owner BUY $10.00 300,000 $3,000,000 3,576,862 +9.2%
2007-11-13 21:37 2007-11-13 MPM BIOVENTURES III QP LP 10% owner BUY $10.00 300,000 $3,000,000 3,576,862 +9.2%
2007-11-13 21:37 2007-11-13 EVNIN LUKE 10% owner BUY $10.00 300,000 $3,000,000 3,576,862 +9.2%
SHOW ENTRIES

How to Interpret $ARYX Trades

Not every insider transaction in ARYX is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ARYX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for ARYX

Insider activity data for ARYX is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ARYX, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.